Carlsbad, CA – According to filings with the U.S. Securities and Exchange Commission, Active Motif is raising $22,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Theodore Defrank played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Active Motif
Active Motif is the industry leader in developing and delivering innovative tools to enable epigenetics and gene regulation research. We are committed to providing the highest quality products and superior service & support to serve the life science, clinical and pharmaceutical/drug discovery communities. Whether you are an expert in the field of epigenetics or a researcher interested in integrating epigenetics research into your studies, Active Motif offers a comprehensive portfolio of epigenetics-related products and services and the support of our team of epigenetic experts to provide complete and innovative solutions to tackle your scientific inquiries.

To learn more about Active Motif, visit http://www.activemotif.com/

Contact:
Theodore Defrank, Chief Executive Officer
760-431-1263
https://www.linkedin.com/in/ted-defrank-1a15153/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved